Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes
Completed
Conditions studied: Parkinson's Disease
In brief
The purpose of this study is to determine the potential for a Parkinson's Disease (PD) -specific breath signature as a non-invasive screening tool for identifying PD patients with inflammation, tracking the progression of disease, and responsiveness to various therapeutic interventions, in particular anti-inflammatory or immunomodulatory therapies. Neurological disorders include any disorder involving the brain or the nervous system, for example memory disorders, stroke, movement disorders and many other conditions. The study will lay the foundation for future studies in which breath fingerprinting could be used as a screening technique. Investigators will also be looking at how the breath fingerprint correlates with inflammatory proteins in the blood.
Key facts
- Study ID
- NCT02749214
- Run by
- Emory University
- People needed
- 100
- Starts
- 2016-02-01
- Expected to finish
- 2019-05-01
- Last updated by the study team
- 2019-06-18
Who can join
Age: 25 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Must be capable of providing written informed consent
- Non-smoking
- Clinical diagnosis of PD Hohn \& Yahr Stages 1 and 2
You may not qualify if…
- Cognitively impaired to the degree that they are not able to provide consent
- Healthy Controls
- Inclusion Criteria:
- Must be capable of providing written informed consent
- Age matched and a family member or healthy community control
- Exclusion Criteria:
- Diagnosed with cancer and/or undergoing cancer treatment.
Where it is running
- The Emory Clinic Executive Park — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.